Effective therapy lies in achieving a therapeutic amount of drug to the proper site in the body and then maintaining the desired drug concentration for a sufficient time interval to be clinically effective for treatment. The blood brain barrier (BBB) hinders most drugs from entering the central nervous system (CNS) from the blood stream, leading to the difficulty of delivering drugsto the brain via the circulatory system for the treatment, diagnosis and prevention of brain diseases. Several brain drug delivery approaches have been developed such as intracerebral and intracerebroventricular administration, intranasal delivery, and blood-to-brain delivery as a result of transient BBB disruption induced by biological, chemical or physical stimuli such as zonula occludens toxin, mannitol, magnetic heating and ultrasound, but these approaches showed disadvantages of being dangerous, high cost as well as unsuitability for most brain diseases and drugs. The strategy of vector-mediated blood-to-brain delivery which involves improving BBB permeability of the drug-carrier conjugate can minimize such side effects; being submicrometre objects that behave as a whole unit in terms of their transport and properties, nanomaterials are promising carrier vehicles for direct drug transport across the intact BBB as a result of their potential to enter the brain capillary endothelial cells by means of normal endocytosis and transcytosis due to their small size, as well as their possibility of being functionalized with multiple copies of the drug molecule of interest. This review provids a concise discussion of nano carriers for drug transport across the intact BBB, various forms of nanomaterials including inorganic/solid lipid/polymeric nanoparticles, nanoemulsions, quantum dots, nanogels, liposomes, micelles, dendrimers, polymersomes and exosomes are critically evaluated, their mechanisms for drug transport across the BBB are reviewed, and the future directions of this area are fully discussed.
Introduction
The increasing incidence of cerebral diseases as a result of the worldwide aging population demands the urgent development of therapeutic, diagnostic, and preventive agents. Whilst brain drug development has been limited, owing to the restrictive transport properties of the blood brain barrier (BBB), which is a unique regulatory system of brain capillaries that protects the brain environment by preventing most molecules in the blood stream from entering the central nervous system [1] [2] [3] [4] [5] [6] . Thus, unlike other organs in the human body, more than 98% of small molecules and nearly 100% of large therapeutic molecules cannot reach brain via the circulatory system [7] .
One strategy for brain drug delivery is bypassing the BBB using highly invasive methods such as intracerebral and intracerebroventricular administration [8] [9] , or non-invasive methods such as intranasal delivery. Another strategy is blood-to-brain delivery via circulatory system as a result of transient BBB disruption induced by biological, chemical or physical stimuli such as zonula occludens toxin, mannitol, magnetic heating and ultrasound [10] [11] [12] [13] . These brain drug delivery strategies have not been widely used because they are risky, costly, or unsuitable for less localized brain diseases [14] .
The strategy of blood-to-brain delivery which involves improving BBB permeability of drugs or drug-carrier conjugates under normal conditions can minimize the above mentioned side effects.
One approach is to modify the chemical structure of drugs; so far only one drug has been successful: the conversion of morphine to heroin [15] [16] . By coupling drugs with various brain nutrients or growth factors, such nutrients/growth factors-mediated delivery showed another promising approach to improve BBB permeability of brain drugs, as specific transporter proteins for brain nutrients/growth factors on the membrane of brain capillary endothelial cells can also facilitate the transfer of some nutrient/growth factor-drug conjugates by means of transcytosis [17] [18] . Unfortunately, this approach is also of little value because only a small number of drugs can be converted to nutrient/growth factor-drug conjugates.
Nanomaterials are submicrometre objects that behave as a whole unit in terms of their transport and properties; it has been found that nanomaterials can internalize into most cells (including brain capillary endothelial cells) by means of normal endocytosis and transcytosis due to "nano effects" as a result of their small size [19] . Consider their possibility of being functionalized with multiple copies of the drug molecule of interest, widespread drug delivery to the brain via the transvascular route through the intact BBB by using nanomaterials as a carrier vehicle which can be dubbed 'Molecular Trojan Horse' is possible [20] [21] [22] [23] . Nanomaterials have been widely investigated for brain drug delivery; in this review paper we discuss: various forms of nanomaterials for blood-to-brain drug delivery through the intact BBB; the mechanisms of nanomaterials-mediated drug transport across the BBB; and the future directions of this innovative area of research.
Nano carriers for drug transport across BBB
Depending on the method of uploading, therapeutic, diagnostic or preventive molecules can be dissolved, entrapped, adsorbed, encapsulated or covalently attached to nanomaterials, to give nano sized drug-carrier conjugates in the forms of nanoparticles, liposomes, micelles, nanogels, nanoemulsions, quantum dots, dendrimers, exosomes, and polymersomes. These objects are in the nanometer (1-1000nm) size range differing markedly from items made of identical materials in the terms of properties and functions. With the minimal diameter of blood capillaries being 6-9 micrometers, nano sized drug-carrier conjugates hold the capability to reach organs via bloodstream. The average size of cells in the human body is 10-20 micrometers; thus, adsorption or uptake of the nano sized drug-carrier conjugates by cells is possible, providing an opportunity to deliver drugs into cells. With the possibility of being surfacely functionalized with targeting ligands, nano carriers offer the capability of transporting drugs across the BBB.
Inorganic nanoparticles
Nanoparticles from inorganic materials such as silica, carbon, metal or metal oxide are solid nano sized particulate objects which have been widely used in imaging techniques [24] . Inorganic nanoparticles are of stable size and form mono-disperse suspensions in body fluids; their surfaces can be functionalized to facilitate BBB penetration. With high surface area, large pore volume, good biocompatibility and ease of functionalization, mesoporous silica nanoparticles have been conjugated with poly(ethylene glycol) (PEG) for BBB penetration as a result of their improved hydrophilicity, the eliminated aggregation in the blood stream, as well as the minimized clearance by the reticuloendothelial system (RES) [25] . The fluorescein-doped magnetic silica nanoparticles (FMSNs) incorporating therapeutic molecules have been covalently conjugated with the second generation (G2) PAMAM (polyamidoamine) dendrimers through 3-(triethoxysilyl) propyl isocyanate (ICP) to yield PFMSNs, followed by the reaction with tresylated MPEG (Methoxypolyethylene glycol)-5000 to yield PEGylated PFMSNs. It has been found that PEGylated PFMSNs could penetrate the intact BBB through transcytosis of vascular endothelial cells, with subsequent diffusion into the cerebral parenchyma and distribution in the neurons. In contrast, non-PEGylated FMSNs were not found to cross the BBB, which showed PEG modification on the surface of the silica nanoparticles may offer an opportunity to cross the BBB.
Just like PEG-modified silica nanoparticles, PEG-modified carbon nanotubes (CNTs) also exhibited the capability of crossing the BBB. CNTs have ultrahigh surface area that permits efficient loading of multiple molecules alongside the nanotube wall, and the supramolecular nanoparticles [27] . Free cationic serum albumin can enter the brain via an adsorptive-transcytosis mechanism; and likewise it has shown that magnetic nanoparticles of MnFe 2 O 4 surfacely coated with crosslinked serum albumin demonstrated the capability of BBB permeability without any breakdown [28] . Other surface coatings, such as poly(isobutylene-alt-1-tetradecene-maleic anhydride) (PMA), also facilitate BBB penetration of iron oxide nanoparticles uploaded with therapeutic molecules [29] .
In addition to chemical modification, physical approaches such as magnetism can also be used for the enhancement of BBB penetration of Fe 3 O 4 nanoparticles because of their capacity to be magnetized in the presence of a magnetic field. It has been found that superparamagnetic iron oxide nanoparticles (SPIONs) composed of magnetite (Fe 3 O 4 ) and maghemite (γ-Fe 2 O 3 ) can pass through human brain microvascular endothelial cells facilitated by an external magnet, which showed the magnetic force-mediated dragging of SPIONs through the BBB may denote a novel mechanism for the delivery of drugs to the brain [30] .
Other inorganic nanoparticles, such as gold nanoparticles (GNPs), have also been investigated for drug transport across the intact BBB [31] . Although all research results showed inorganic nanoparticles are promising carrier vehicles to deliver drugs into brain, the issues of potential toxicity as a result of non-degradability and drug delivery efficiency still need to be addressed [32] . heart and reticuloendothelial cells-containing organs after intravenous injection in comparison to free camptothecin, which indicated that it was possible for the SLNs to cross the BBB [35] . SLNs made from stearic acid stabilized with pluronic®F68 showed the possibility to effectively deliver atazanavir to human brain endothelial cells in vitro [36] ; In vivo test in rats also showed that riluzole-uploaded SLNs exhibited a higher capability to carry the drug into the brain [37] .
Solid lipid nanoparticles
Surface modification of SLNs with targeting ligands could be an effective strategy for BBB delivery. Docetaxel-loaded SLNs have been prepared from monostearin, vitamin E and soya lecithin, followed by surface modification with stearylamine-betreliesoxybutyric acid (HBA, a ketone body and substrate for monocarboxylic acid transporter which is expressed on BBB) conjugate, for drug transport across the intact BBB [38] . The surface modification of docetaxel loaded SLNs with HBA resulted in enhanced brain uptake of docetaxel compared with un-modified docetaxel loaded SLNs and Taxotere®, which showed HBA present on the surface of SLNs caused the nanoparticles to be taken up by the monocarboxylic acid transporter as normal HBA and improved the brain uptake of docetaxel compared with un-modified SLNs. Similarly, Transferrin (Tf)-conjugated, quinine dihydrochloride-uploaded SLNs made from hydrogenated soya phosphatidyl choline (HSPC), triolein, distearylphosphatidylethanolamine (DSPE) and cholesterol revealed enhanced uptake in brain tissue compared with un-conjugated SLNs [39] ; it has also been demonstrated that poly(ethylene glycol)-grafted SLNs made from stearate using egg phosphatidyl choline and sodium glycocholate as surfactants uploaded with noscapine can improve drug accumulation in mice brain tissue [40] .
Acting as a carrier vehicle for drug delivery, SLNs have shown the advantages of good biocompatibility, degradability as well as the capacity to be surfacely functionalized for brain targeting, while the issue of easy clearance by the RES as a result of their hydrophobicity needs to be addressed.
Polymeric nanoparticles
Polymeric nanoparticles are solid carrier vehicles ranging from 1 to 1,000 nm in diameter made from natural or synthetic polymers. According to the drug loading methods, therapeutic molecules-uploaded polymeric nanoparticles can form nanospheres (drugs are uploaded throughout or just onto the surface of the polymeric matrix) or nanocapsules (drugs are surrounded by a polymeric shell) which are thermodynamically stable [41] . As a result of the diversity of polymers, polymeric nanoparticles can be designed to achieve desired properties such as controlled and/or sustained drug release profile, as well as allowing drug release at the targeted site over a period of time [42] . For this reason, a variety of polymers have been investigated to form nanoparticles for brain drug delivery. β-cyclodextrin, which is composed of cyclic oligosaccharides with seven glucose unites that form a hydrophobic central cavity with the capacity to host therapeutic molecules, has been quarternized for the preparation of a series of quaternary ammonium β-cyclodextrin (QA-CD) nanoparticles. Uploaded with doxorubicin (DOX), QA-CD nanoparticles showed permeability across the in vitro BBB by means of endocytosis [43] .
DOX-uploaded nanoparticles of β-cyclodextrin crosslinked with β-amino ester also showed biocompatibility and permeability in an in vitro BBB model without impairing the integrity of the barrier [44] . Another synthetic polymer, namely poly(MePEG2000cyanoacrylate-co-hexadecylcyanoacrylate) (PEG-PHDCA), demonstrated the capacity of their nanoparticles to reach the rat central nervous system after intravenous injection [45] . In contrast, polyhexadecylcyanoacrylate (PHDCA) nanoparticles did not penetrate across the BBB as a result of less adsorbed apolipoprotein E (ApoE) as well as apolipoprotein B-100 (ApoB-100) than PEG-PHDCA nanoparticles, which demonstrated that the involvement of apolipoproteins played an important role in the brain transport of PEG-PHDCA nanoparticles [46] .
It has been found that some surfactants can enhance the permeability of polymeric nanoparticles across the BBB; poly(butylcyanoacrylate) (PBCA) nanoparticles coated with polysorbate 80 have been successfully used to transport drugs such as leu-enkephalin dalargin, met-enkephalin kyotorphin, rivastigmine and tacrine through the BBB after intravenous injection [47] [48] [49] [50] [51] . PBCA is a biodegradable and biocompatible polymer; PBCA nanoparticles showed hardly any cytotoxic or inflammatory effect at therapeutic concentrations and incubation times, and they did not induce nonspecific BBB disruption, but collaborate with plasma apolipoprotein E to facilitate BBB crossing [52] [53] .
Poly(lactic-co-glycolic acid) (PLGA) is a polymer with biodegradable and biocompatible nature which has been approved by the US FDA for human use. Research has shown that PLGA nanoparticle-delivered dopamine reduced its autoxidation-mediated toxicity in the brain, and reversed neurochemical and neurobehavioral deficits in parkinsonian rats [54] . When uploaded with a protein drug (tissue inhibitor of matrix metalloproteinases 1, TIMP-1), PLGA nanoparticles coated with polysorbate 80 had 11.21%±1.35% penetration, whereas TIMP-1 alone and PLGA nanoparticles without polysorbate 80 coating did not cross the endothelial monolayer. Due to no significant opening of the BBB caused by un-coated as well as polysorbate 80 coated PLGA nanoparticles, polysorbate 80 coating can be used to enhance protein delivery of PLGA nanoparticles across the BBB [55] .
In addition to coating with surfactants, surface functionalization with certain peptides can also facilitate BBB penetration of polymeric nanoparticles. Surface-modified PLGA nanoparticles with octa-arginine (R8) showed a faster cell uptake compared with the control [56] , while the fluorescent aminated polystyrene (PS) nanoparticles surfacely functionalized with gH625 (a viral fusion peptide derived from the glycoprotein gH of Herpes simplex virus type I) via a covalent binding procedure showed a greater uptake by brain endothelial cells than that of the PS nanoparticles without the peptide [57] . Modification with a motif of TGNYKALHPHNG (TGN)
could facilitate BBB penetration of poly(ethylene glycol)-poly(DL-lactide-co-glycolide) (PEG-PLGA) nanoparticles, leading to significant higher cellular uptake and in vivo brain accumulation [58] .
As a result of receptor-mediated endocytosis being one of the mechanisms through which nano After intravenous administration, near 3 folds of coumarin-6 were found in the mice brain carried by Lf-conjugated nanoparticles compared to that carried by the bare nanoparticles.
Campared with synthetic polymers, nanoparticles based on natural polymers showed advantages of low cost, less toxicity and biodegradability, which provide a potential candidate for brain drug delivery. A pluronic-based nano-carrier conjugated with both chitosan and a specific target peptide for brain (rabies virus glycoprotein; RVG29) was effective for brain targeting across the intact BBB [63] . Chitosan nanospheres conjugated with an anti-mouse transferrin receptor monoclonal antibody (TfRMAb) that selectively recognizes the TfR type 1 on the cerebral vasculature clearly demonstrated the effectiveness of bringing active peptides to the brain [64] .
Chitosan nanospheres conjugated with poly(ethylene glycol) (PEG) bearing the OX26 monoclonal antibody whose affinity for the transferrin receptor (TfR) may trigger receptor-mediated transport across the BBB successfully translocated into the brain tissue after intravenous administration [65] .
Due to hydrophobic molecules exhibiting better permeability in BBB penetration than hydrophilic ones, chitosan has been chemically modified to improve hydrophobicity for permeability improvement of the nanoparticles in BBB penetration. Trimethylated chitosan (TMC) has been synthesized and covalently coupled to the surface of PLGA nanoparticles (PLGA-NP) via a carbodiimide-mediated link, the resulted nanoparticles exhibited negligible cytotoxicity and enhanced brain uptake following intravenous administration compared with PLGA nanoparticles without TMC conjugation [66] . A series of O-substituted alkylglyceryl chitosans with systematically varied alkyl chain length and degree of grafting has been prepared through synthetic steps that involved the protection of amino moieties via phthaloylation and employed for the formulation of aqueous nanoparticulate systems. During in vitro tests using a mouse-brain endothelial cell model, the efficient cellular uptake of these nanoparticles has demonstrated and identified butylglyceryl chitosan and butylglyceryl N,N,N-trimethyl chitosan as promising materials for the formulation of nanoparticles that could act as drug carriers into the brain [67] .
With the possibility of achieving designed and tailored properties, polymeric nanoparticles have significant potential for brain drug delivery across the BBB. Biodegradable polymers exhibit the advantage of less accumulation in the body; however, before translation into clinical use, a good knowledge of degradation rates as well as catabolites, toxicity, and the possibility of causing adverse immunological responses is necessary.
Nanogels
Gels are physically or chemically crosslinked 3-dimensional polymeric networks that swell in certain liquids with compatible interfacial energies, and the swollen networks can retain a large amount of absorbed liquids [68] . Both aqueous and organic liquids can be supporting media of polymeric gels, leading to the formation of hydrogels and organic gels, respectively [69] . With good biocompatibility as a result of their relatively high water content, as well as the possibility of pharmaceutical molecules to diffuse into (drug loading) and out of (drug release) the swollen polymeric networks, hydrogels have been widely investigated for drug delivery [70] [71] .
Nanogels are nanoparticles of hydrogels and offer the prospect of drug transport across the intact BBB. It has been reported that nanogels with surface charge exhibited better internalization property on cell membrane than neutral ones; Gil and Lowe synthesized polysaccharide-based nanogels containing poly(β-amino ester) and β-cyclodextrin for transporting doxorubicin and insulin across the BBB, such cationic nanogels enhanced the permeability of insulin across the in vitro BBB model by 20% [72] .
It is known that lipophilic molecules are easier to penetrate the BBB than hydrophilic ones; so surface functionalization of nanogels has been introduced to accelerate encapsulated drug transport across the BBB. Azadia and co-workers prepared nanogels loaded with methotrexate (MTX) via an ionic gelation process using chitosan and sodium tripolyphosphate (TPP) as raw materials, the surfaces of the MTX-loaded nanogels were modified with polysorbate 80 to improve brain drug delivery [73] . The cumulative in vitro release profiles indicated non-Fickian diffusion kinetic, apparently governed by both diffusion of the drug out of the nanogels and swelling/disintegration of the polymeric networks for both surfactant coated and uncoated nanogels. After intravenous administration, remarkably higher brain concentrations of methotrexate were achieved with the nanogel formulations in comparison to the free drug, but there were no significant differences between the surface-coated and uncoated nanogels [74] .
Two proteins, connexin 43 (Cx43) and brain-specific anion transporter 1 (BSAT1), which are promising targeted antigens for drug delivery to gliomas, have been respectively conjugated with the cisplatin-loaded nanogels prepared from aqueous solutions of poly(ethylene glycol) (PEG)-block-poly(methyl methylacrylate) (PMAA) and CaCl 2 using 1,2-ethylenediamine and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) as crosslinkers, for the treatment of intracranial gliomas [75] . The median survival of rats treated with targeted nanogels conjugated with specific mAbs against extracellular loops of Cx43 and BSAT1 were 27 and 26.6 days longer than that in control group, respectively, which suggested the effectiveness of the ligands in promoting BBB-penetrating efficiency of the nanogels. Conjugation of insulin and Tf with the nanogels of crosslinked poly(ethylene glycol) and poly(ethylenimine) for the delivery of oligonucleotide in brain also showed similar results [76] . Being hydrophilic carriers, nanogels are favorable in uploading aqueously soluble drugs as well as proteins and nuclear acids, while it is unsuitable for hydrophobic drugs.
Micelles
Micelles are made from amphiphilic block copolymers which aggregate in aqueous solutions to form stable spheroidal nano structures with a hydrophobic core and hydrophilic surface [77] . derived from the Kunitz domain) [80] [81] [82] . However, the efficiency of micelles delivering drugs across the intact BBB still needs further investigation.
Liposomes
Liposomes are nano sized vesicles with an aqueous inner core enclosed by unilamellar or multilamellar phospholipid bilayers. The common constituents that form part of phospholipid bilayer are naturally produced sphingomyelin, phosphatidylcholine, or glycerophospholipids [84] .
With good biocompatibility, as well as the possibility of uploading drugs in the aqueous core, liposomes have been widely investigated for systemic delivery of therapeutics [85] .
Several issues have impeded the drug delivery application of conventional liposomes; one is opsonization and rapid clearance by macrophages of the mononuclear phagocytic system (MPS) organs. By using surface coatings such as poly(ethylene glycol) (PEGylated liposomes), the circulation time of liposomes in the body can be prolonged [86] . Other issues limiting the brain delivery of liposomes are the poor stability, as well as the difficulty of binding ligands to the surface as a result of the small number of available surface groups and steric hindrance.
Dendrimers
Dendrimers are monodisperse symmetric macromolecules that comprise a series of branching units around an inner core [91] . With many reactive groups on the surface, the number of arms and surface groups exponentially increase with each generation [92] .
Being composed of repetitive units of branched molecules, dendrimers form a 3-dimensional spheroidal shape and radially crowded layers. As a result, the core is loosely packed in comparison to the periphery and is suitable for the entrapment of drugs. In addition, the presence of numerous surface groups allows for high drug payload and/or multifunctionality. Combined with their nanometer size range, dendrimers are attractive carrier vehicles for drug delivery [93] .
The surface groups of dendrimers can be conjugated with ligands for transport across the BBB, as well as for targeting specific cells such as tumor cells. Thus, dendrimers are promising tailorable delivery systems for improved delivery of drugs to the brain. Li and co-workers have synthesized the fourth generation poly(amidoamine) (PAMAM) dendrimers with transferrin (Tf) conjugated on the exterior and tamoxifen (TAM) encapsulated in the interior [94] . It has been found that each dendrimer is a pH-sensitive drug carrier that can encapsulate 29 TAM molecules in the interior, and bond 7 doxorubicine (DOX) molecules, over 30 PEG1000 and PEG2000 chains and one Tf group on the periphery. The drug-dendrimer conjugate showed a fast drug release profile at weak acidic condition and a stable state at physiological environment, as well as a good BBB transportation ability with the transporting ratio of 6.06% in 3h. Angiopep, a ligand targeting to the low-density lipoprotein receptor-related protein-1 (LRP1), has been conjugated with PAMAM dendrimers for effective brain-targeting gene delivery [95] . Such a nano carrier was observed to be internalized by brain capillary endothelial cells (BCECs) through a clathrin-and caveolae-mediated energy-depending endocytosis, also partly through marcopinocytosis.
Compared with the dendrimers without modification, angiopep-modified dendrimers showed higher efficiency in crossing the intact BBB, and more in vivo accumulation in the brain. Other research results also showed the capacity of targeting ligand conjugated dendrimers to cross the intact BBB [96] [97] .
Before translation of dendrimers into brain drug delivery use, it is necessary to address their biocompatibility issue. For example, PAMAM dendrimers have been shown to be haemolytic and cytotoxic [98] . Some research results also showed that biotinylated PAMAM dendrimers may prove to be more toxic compared to PAMAM dendrimers alone [99] .
Nanoemulsions
Nanoemulsions Compared with other nano carriers, the advantages of nanoemulsions for overcoming the BBB are the ability to utilize safe oils, as well as possessing several beneficial biological properties as a result of essential omega-3 and omega-6 fatty acid in the oils. However, the thermodynamic instability is a shortcoming of nanoemulsions and requires further considersation.
Exosomes
Exosomes are a kind of nano sized membranous vesicle secreted by a number of cell types and can be isolated from conditioned cell media or bodily fluids such as urine and plasma [104] . Once released from a cell, exosomes can fuse with membrane of another cell, transferring exosomal molecules from one cell to another [105] . This property provides exosomes with the chance to transport drugs into cells. The uptake mechanism of exosomes is clathrin mediated endocytosis followed by back fusion with the limiting membrane of the endosomes, allowing for the possibility of exosomes to cross the intact BBB [106] .
Being secreted by living cells in the body, exosomes are natural delivery vehicles with advantages of non-toxicity, minimal immune responses, and better stability in the circulatory system in contrast to established formulations [107] . Alvarez-Erviti and co-workers used self-derived dendritic cells for exosome production; targeting peptides for muscle and brain were used to functionalize the exosomes [108] . Uploading exogenous siRNA onto the exosomes by electroporation, it has been found that the exosomes delivered siRNA specifically to neurons, microglia, and oligodendrocytes in the brain, resulting in a specific gene knockdown after intravenous injection. Yang and co-workers isolated four types of exosomes from brain cell culture media for drug delivery, and found that exosome-delivered anticancer drugs crossed the intact BBB and entered into the brain [109] .
Proof of concept has been gained for exosome-based brain drug delivery systems; several issues should be addressed before clinical evaluation such as the choice of exosome donor cells, drug loading procedures, as well as the targeting peptides.
Quantum dots
Quantum dots are a class of colloidal semi-conductor nano crystals composed of a metalloid crystalline core (such as cadmium selenium) and an intermediate unreactive metallic shell (such as zinc sulfide) that shields the core [110] . Such an inorganic nano material has high brightness, long-term photo-stability, and size-tunable narrow emission spectra, which makes it a revolutionary imaging technology for diagnostic purposes (fluorescent probes) [111] . With the possibility of being co-incorporated with a variety of diagnostic and therapeutic molecules for targeted therapy of CNS disorders as a result of their high surface area, quantum dots also showed the potential as a carrier vehicle for blood-to-brain drug delivery.
The outer coating of quantum dots can be chemically functionalized with bioactive molecules that promote aqueous solubility and desired bioactivity, enable targeting of specific molecules, as well as carrying therapeutic molecules [112] . Captopril-conjugated CdSe/ZnS-core/shell-typed quantum dots (QDs-cap) have been synthesized by the hot soap method with tri-n-octyl phosphine oxide (TOPO) followed by the replacement of TOPO with captopril by a thiolexchange reaction.
It has been found that intraperitoneally administered QDs-cap in mice were delivered through systemic blood circulation into the brain as well as into the liver, spleen and kidney, which showed the possibility of such quantum dots to penetrate the BBB [113] .
It is widely known that the Tf receptor is a kind of specific BBB transporter that allows selected biomolecules to move across the BBB; lysine-coated CdSe/CdS/ZnS quantum dots have been synthesized followed by conjugation with Tf. It has been found that the migration rate of such Tf-conjugated QDs crossing the in vitro BBB model was concentration-and time-dependent after a systemic administration, which demonstrated a receptor-mediated transport mechanism [114] .
TAT, a cell membrane translocation peptide, has been successfully used to internalize nanoparticles [115] . Research has shown that TAT-conjugated CdS:Mn/ZnS quantum dots can label the brain tissue within a few minutes after being intra-arterially delivered to a rat brain without manipulating the BBB; such TAT-conjugated quantum dots migrated beyond the endothelial cell line and reached the brain parenchyma [116] [117] . Because the same quantum dots without TAT did not label the brain tissue, TAT peptide was necessary for the quantum dots to overcome the BBB.
Polymersomes
Polymersomes are a nanometer-sized vesicular system with a bi-layered membrane which is composed of amphiphilic block copolymers [118] . Such tiny hollow spheres can be formed from synthetic amphiphilic block copolymers using organic solvent, organic solvent/water systems, or aqueous media. Usually, amphiphilic block copolymers with a hydrophilic fraction of 35±10% will aggregate to form polymersomes [119] [120] .
Polymersomes enclose an aqueous solution in the core, which is useful for encapsulation and delivery of hydrophilic drugs, while the membrane of copolymer aggregates bi-layer can be loaded with small hydrophobic drugs [121] [122] . Polymersomes are similar to liposome in structure; the main difference is that the external bi-layer is composed of amphiphilic copolymers with a molecular weight of up to 100 kDa, while the building block of liposome is in most cases naturally occurring phospholipid with a molecular weight below 1 kDa [123] [124] . With regard to the use of building blocks with high molecular weight, the membrane of polymersomes is thicker than that of liposome, providing a higher durable physical barrier that protects the enclosed drugs [125] . When used for drug delivery, the more robust and therefore less leaky membrane of polymersome can improve circulation time and prevent uncontrolled release of drugs [126] [127] .
Being a nano carrier vehicle, polymersomes have been functionalized with certain receptors for brain drug delivery across the BBB. Pang and co-workers synthesized biodegradable poly(ethyleneglycol)-poly(ε-caprolactone) (PEG-PCL) and used the block copolymer to prepare polymersomes (PO) by a nano precipitation method [128] . To facilitate brain targeting, the polymersomes were functionalized with Tf to form a conjugate Tf-PO. Using coumarin-6 as a model drug, fluorescent microscopy of brain coronal sections revealed more Tf-PO than PO accumulated in the brain after injection, and it has been evidenced that Tf-PO uptake by beta-End.3 cells occurred mainly through a clathrin-mediated, energy-dependent endocytosis and that both the Golgi apparatus and lysosomes were involved in intracellular transport of Tf-PO. (des-octanoyl ghrelin-PEGGM-PDSGM) copolymer, poly(tert-butyl hydrazinecarboxylate ethylene glycol-g-glutamate)-co-poly(distearin-g-glutamate) (BPEGGM-PDSGM) copolymer, as well as folate-poly(ethylene glycol-g-glutamate)-co-poly(distearin-g-glutamate)
(folate-PEGGM-PDSGM) copolymer have been prepared, different types of polymersomes based on such copolymers have been developed and conjugated with both des-octanoyl ghrelin and folate as a penetrating-targeting carrier for an enhanced drug transport through the BBB and glioma cells targeting [131] . It has been found that with bi-functional ligands on the surface of polymersomes, the BBB transport was greatly enhanced and the inhibition of glioma growth was significantly improved via a synergistic effect of two different endocytosis mechanisms by des-octanoyl ghrelin and folate.
Although several research results showed the possibility of receptor functionalization-mediated BBB penetration of polymersomes, the efficiency of drug transport was not ideal. In addition, the application of protein and antibody receptors is restricted by their instability and immunogenicity.
Mechanisms of nanomaterials transporting drugs across the BBB
Based on the biological characteristics of the BBB, the mechanisms of nano carriers transporting drugs across the BBB can be classified as follows: (1) It has been found that some chitosan-derived nanoparticles were capable of opening the tight junctions of the BBB [135] [136] , while high concentrations of some anionic nanoparticles and cationic nanoparticles disrupted the BBB even though neutral nanoparticles and low concentrations of anionic nanoparticles have no effect on BBB integrity [137] . Sodium dodecylsulphate, a surfactant which is regarded as biocompatible, has also been found the capability to induce a breach in the blood brain barrier [138] . Transient BBB opening as a result of the stimulus derived from nano carriers or surfactants is dangerous as a result of the nano carrier's toxicity, as well as the possibility of other molecules in blood stream diffusing into the brain parenchyma at the same time.
Adsorption of the drug-carrier conjugates onto the surface of brain capillary endothelial cells depends on hydrophilicity, surface charge, and targeting ligands of the nano carrier. A lipophilic surface of the nano carrier facilitates the adsorption; and a positive surface charge of the nano carrier promotes electrostatic interactions with the negative charges of endothelial surfaces which also facilitate the adsorption [139] [140] . Targeting ligands such as the apolipoproteins in plasma adsorbed on the surface of the nano carrier can target low density lipoprotein receptors on the microvessel endothelial cells, which facilitates the adsorption [141] .
For the fate of drug-carrier conjugates adsorbed on the surface of brain capillary endothelial cells, one is desorption followed by re-entering the blood stream. In this case, the uploaded drug can release from the carrier vehicle on the surface of BBB during adsorption and then diffuse into the brain parenchyma through the BBB. Therefore, the possibility of drug penetrating into the brain parenchyma will be determined by characteristics of the drug. To promote drug transport across the BBB, it is necessary to modify the surface of the nano carriers for the minimization of clearance by the fixed macrophages of the mononuclear phagocytic system (MPS) and prolonged blood circulation enhancing exposure of the BBB. Improving hydrophilicity and increasing surface charge are good methods for nano carriers to mask themselves from the MPS. Another fate of the adsorbed drug-carrier conjugates is endocytosis by the cells, sometimes followed by exocytosis, leading to penetration of the nano carrier into the cells or brain parenchyma.
Endocytosis may occur by means of random uptake of soluble plasma molecules together with a bulk of plasma by caveolaes on the cells; such a process is independent of any interaction between the transported molecules and the caveolar vesicle membrane [142] . Because the brain capillary endothelial cells are characterized by few caveolaes while a high density of negatively charged and clathrin-coated pits through which drug-carrier conjugates can be be endocytosed, endocytosis of drug-carrier conjugates is mainly based on the adsorption of drug-carrier conjugates to the clathrin-coated pit membrane [143] .
Although it is a normal biological function of cells, endocytosis is energy-dependant which does not exhibit any preference for nano carriers conjugated with drugs, leading to a low efficiency of drug transport across the BBB. Several approaches have been proposed to promote endocytosis of nano carriers by brain capillary endothelial cells; one is coating the nano carriers with surfactants whose effectiveness has been testified. Three mechanisms have been proposed to explain surfactant-coating promoted endocytosis, namely [144] [145] [146] [147] [148] : (1) 
Perspective
Brain drug delivery via the circulatory system is limited by the BBB, which hinders therapy, diagnosis and prevention of cerebral diseases. Being a non-invasive approach, rapid opsonization, the fast and non-specifc clearance from the circulatory system by reticulo-endothelial system (RES) cells of nano carriers with hydrophobic/neutral surfaces; the metastable nature of some nano carriers; limited drug loading capacity; need to co-formulate with surfactants and co-solvents; aggregation or cluster formation in blood flow of neutral or hydrophobic nano carriers; and the most importantly, the low efficiency of crossing the intact BBB, leading to the difficulty of achieving effective local drug concentration in the brain parenchyma.
According to the various mechanisms of drug transport across BBB by nano carriers, only penetration of drug-carrier conjugates into the brain parenchyma via transcytosis or endocytosis exhibit suitability for all types of brain drugs. Therefore, to obtain a pratical delivery platform for brain drugs, it is suggested here that the development of a versatile delivery platform should focus on their capability as well as efficiency to be transcytosed or endocytosed.
In addition, the fate of drug carrier vehicles in the brain is a primary consideration. The first requirement for drug carrier vehicles is biocompatibility; compared with drug carrier vehicles targeting other organs, the accumulation of nano carriers in the brain parenchyma is a particular issue to be addressed in addition to toxicity and immunological response. Biodegradable nano carriers or nano carriers with the capability to penetrate out of the brain parenchyma across the intact BBB after drug release which can be removed by MPS are preferable. Unfourtunately, at present it is still unclear what effects of nano carrier's accumulation in the brain parenchyma will be.
Lastly, to achieve the minimal effective drug concentration in brain parenchyma while the maximal safety drug concentration is not exceeded in other organs, the drug transport efficiency across the BBB by nano carriers should be elevated. 
